Results 11 to 20 of about 23,100 (268)
Sciatic neuropathy developed after injection during curettage
Intramuscular injections are likely the most common cause of sciatic nerve injury in developing countries. Less common causes include piriformis syndrome, primary tumors of the sciatic nerve, metastatic tumors invading or compressing the nerve, endometriosis, vascular malformations, and prolonged immobilization or positioning.
Ayşe, Altıntaş +5 more
openaire +3 more sources
Reply to the Letter to the Editor for "Use of fluoroscopic-guided transsacral block for the treatment of iatrogenic post-injection sciatic neuropathy: Report of three cases". [PDF]
Şencan S, Cüce İ, Gündüz OH.
europepmc +2 more sources
An unusual sciatic neuropathy. [PDF]
F, Tison, P, Boulan
openaire +4 more sources
Bilateral sciatic neuropathy with severe rhabdomyolysis following venlafaxine overdose: A case report. [PDF]
Ko JU, Seo H, Lee GJ, Park D.
europepmc +2 more sources
Electrodiagnostic features of sciatic neuropathy: Six-year referral center experience
Introduction: Sciatic neuropathy is one of the most important neuropathies of the lower extremity. Although electromyography (EMG) is useful for detecting and localizing neurologic damage, assessing the severity of neuropathy, determining prognoses, and ...
Fatma Gokcem Yildiz +3 more
doaj +1 more source
Dyslipidemia has been considered a risk factor for diabetic peripheral neuropathy. Proprotein convertase subtilisin-like/Kexin 9 inhibitor (PCSK9) inhibitors are a new type of lipid-lowering drug currently in clinical use.
Na Cui +6 more
doaj +3 more sources
Little is known regarding the pharmacological properties of extended-release local anesthetics in the setting of diabetic peripheral neuropathy. We investigated and compared the duration of sciatic nerve block following administration of clinically ...
Liljana Markova +5 more
doaj +1 more source
Tadalafil Promotes the Recovery of Peripheral Neuropathy in Type II Diabetic Mice. [PDF]
We previously demonstrated that treatment of diabetic peripheral neuropathy with the short (4 hours) half-life phosphodiesterase 5 (PDE5) inhibitor, sildenafil, improved functional outcome in diabetic db/db mice.
Lei Wang +7 more
doaj +1 more source
Sciatic neuropathy with preserved sensory nerve action potentials, a case series [PDF]
Background: Sciatic neuropathy is differentiated from lumbosacral radiculopathy based on the finding of abnormal sensory nerve action potentials (SNAPs). Cases of sciatic neuropathy with intact SNAPS have not been well described. Methods: A retrospective
Li, Yuebing +2 more
core +2 more sources
Molsidomine ameliorates diabetic peripheral neuropathy complications in Wistar rats
Diabetic neuropathy is a disorder that affects various regions of the nervous system and there is no specific treatment available for it. This study evaluated the protective effect of molsidomine in diabetic neuropathy in rats.
Pranav Nayak B +2 more
doaj +1 more source

